Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minyoung Jang

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology Reports|January 22, 2026
Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategiesMinyoung Jang, Stefan Gysler, Nawar A Latif, et al.
The Lancet. Oncology|May 4, 2020
Cancer in Syrian refugees in Jordan and Lebanon between 2015 and 2017Paul B Spiegel, Joseph G Cheaib, Saad Abdel Aziz, et al.
BMJ Evidence-Based Medicine|June 5, 2020
COVID-19 and the US response: accelerating health inequitiesNneoma E Okonkwo, Ugochi T Aguwa, Minyoung Jang, et al.
Plos One|September 27, 2013
Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinomaBin Yan, Huai Li, Xinping Yang, et al.
Clinical Kidney Journal|February 5, 2026
Comparative renal safety: potassium-competitive acid blockers vs proton pump inhibitorsMinyoung Jang, Sungmi Kim, Minhyung Kim, et al.
Head & Neck|July 14, 2012
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology GroupJill Gilbert, Ju Whei Lee, Athanassios Argiris, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 29, 2023
Recent Advances in the Genetic Pathogenesis, Diagnosis, and Management of Esophageal Atresia and Tracheoesophageal Fistula: A ReviewDelia O'Shea, Nicholas Schmoke, Chloe Porigow, et al.
Expert Opinion on Biological Therapy|August 7, 2025
Perceived benefits and cost savings of liquid formulation of intravenous infliximab: perspectives of seven European countriesKyoungwan Nam, Taek Sang Kwon, Federico Di Biasio, et al.
Kidney International Reports|September 22, 2025
The Protective Effects of SGLT-2 Inhibitors Against Postoperative Acute Kidney Injury in Type 2 DiabetesSeung Min Song, Minji Kim, Minyoung Jang, et al.
Journal of Surgical Education|June 7, 2021
A Qualitative Study of the Barriers and Benefits to Resident Education in Ambulatory Surgical CentersAndrew D Zale, Christopher I Song, Ashley Zhou, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology Reports|January 22, 2026
Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategiesMinyoung Jang, Stefan Gysler, Nawar A Latif, et al.
The Lancet. Oncology|May 4, 2020
Cancer in Syrian refugees in Jordan and Lebanon between 2015 and 2017Paul B Spiegel, Joseph G Cheaib, Saad Abdel Aziz, et al.
BMJ Evidence-Based Medicine|June 5, 2020
COVID-19 and the US response: accelerating health inequitiesNneoma E Okonkwo, Ugochi T Aguwa, Minyoung Jang, et al.
Plos One|September 27, 2013
Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinomaBin Yan, Huai Li, Xinping Yang, et al.
Clinical Kidney Journal|February 5, 2026
Comparative renal safety: potassium-competitive acid blockers vs proton pump inhibitorsMinyoung Jang, Sungmi Kim, Minhyung Kim, et al.
Head & Neck|July 14, 2012
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology GroupJill Gilbert, Ju Whei Lee, Athanassios Argiris, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 29, 2023
Recent Advances in the Genetic Pathogenesis, Diagnosis, and Management of Esophageal Atresia and Tracheoesophageal Fistula: A ReviewDelia O'Shea, Nicholas Schmoke, Chloe Porigow, et al.
Expert Opinion on Biological Therapy|August 7, 2025
Perceived benefits and cost savings of liquid formulation of intravenous infliximab: perspectives of seven European countriesKyoungwan Nam, Taek Sang Kwon, Federico Di Biasio, et al.
Kidney International Reports|September 22, 2025
The Protective Effects of SGLT-2 Inhibitors Against Postoperative Acute Kidney Injury in Type 2 DiabetesSeung Min Song, Minji Kim, Minyoung Jang, et al.
Journal of Surgical Education|June 7, 2021
A Qualitative Study of the Barriers and Benefits to Resident Education in Ambulatory Surgical CentersAndrew D Zale, Christopher I Song, Ashley Zhou, et al.
Pageof 6